Alpha Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$539K Buy
466
+14
+3% +$16.5K 0.14% 47
2026
Q2
$542K Hold
452
– – 0.14% 48
2026
Q1
$415K Buy
452
+1
+0.2% +$1.01K 0.13% 36
2025
Q4
$484K Hold
451
– – 0.15% 37
2025
Q3
$344K Sell
451
-3
-0.7% -$2.23K 0.12% 38
2025
Q2
$354K Buy
+454
New +$353K 0.14% 36

Other funds holding LLY

Alpha Financial Advisors's LLY Position: Q3 2026 in Review

Alpha Financial Advisors increased its Eli Lilly (LLY) stake by 3.1% in Q3 2026, buying an estimated $16.5K and bringing the position to 466 shares worth $539K. The position accounts for 0.14% of the portfolio, ranked #47.

Alpha Financial Advisors first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $542K in Q2 2026. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Alpha Financial Advisors held 466 shares of Eli Lilly worth $539K as of Q3 2026.
  • Alpha Financial Advisors bought 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
  • Eli Lilly made up 0.14% of Alpha Financial Advisors's portfolio in Q3 2026, its #47 holding.
  • Alpha Financial Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • Alpha Financial Advisors's Eli Lilly position peaked at $542K in Q2 2026.
  • 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Alpha Financial Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.